3,544 Shares in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Bought by Cerity Partners LLC

Cerity Partners LLC bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 3,544 shares of the company’s stock, valued at approximately $276,000.

Several other large investors have also bought and sold shares of ACHC. Campbell & CO Investment Adviser LLC raised its position in shares of Acadia Healthcare by 177.4% in the 3rd quarter. Campbell & CO Investment Adviser LLC now owns 7,357 shares of the company’s stock worth $517,000 after acquiring an additional 4,705 shares in the last quarter. Vaughan Nelson Investment Management L.P. bought a new position in shares of Acadia Healthcare in the 4th quarter worth about $24,157,000. Raymond James Financial Services Advisors Inc. raised its position in shares of Acadia Healthcare by 109.3% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 44,300 shares of the company’s stock worth $3,445,000 after acquiring an additional 23,138 shares in the last quarter. Jennison Associates LLC raised its position in shares of Acadia Healthcare by 5.5% in the 3rd quarter. Jennison Associates LLC now owns 910,641 shares of the company’s stock worth $64,027,000 after acquiring an additional 47,491 shares in the last quarter. Finally, California Public Employees Retirement System raised its position in shares of Acadia Healthcare by 112.6% in the 3rd quarter. California Public Employees Retirement System now owns 368,382 shares of the company’s stock worth $25,901,000 after acquiring an additional 195,130 shares in the last quarter.

Insider Transactions at Acadia Healthcare

In other news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 2.80% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the company. Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a research report on Monday, March 4th. TD Cowen boosted their target price on Acadia Healthcare from $86.00 to $101.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 target price for the company in a research report on Thursday. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, March 5th. Finally, Barclays initiated coverage on Acadia Healthcare in a research report on Wednesday, March 6th. They issued an “overweight” rating and a $100.00 target price for the company. Four equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $92.00.

Acadia Healthcare Price Performance

ACHC stock opened at $73.59 on Monday. The company has a market capitalization of $6.80 billion, a P/E ratio of -294.36, a price-to-earnings-growth ratio of 2.17 and a beta of 1.31. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.67. Acadia Healthcare Company, Inc. has a 52-week low of $66.49 and a 52-week high of $87.77. The business has a 50-day simple moving average of $78.07 and a two-hundred day simple moving average of $77.74.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.05. The business had revenue of $742.80 million during the quarter, compared to the consensus estimate of $727.60 million. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The company’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.70 EPS. Research analysts expect that Acadia Healthcare Company, Inc. will post 3.57 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.